TY - JOUR
T1 - Transient Glycolytic Complexation of Arsenate Enhances Resistance in the Enteropathogen Vibrio cholerae
AU - Bueno, Emilio
AU - Pinedo, Víctor
AU - Shinde, Dhananjay D.
AU - Mateus, André
AU - Typas, Athanasios
AU - Savitski, Mikhail M.
AU - Thomas, Vinai C.
AU - Cava, Felipe
N1 - Funding Information:
The metabolomics analyses were performed at the University of Nebraska Medical Center Mass Spectrometry and Proteomics Core Facility administered through the Office of the Vice Chancellor for Research and supported by state funds from the Nebraska Research Initiative (NRI). We thank Erik Björk and Laurent Ouerdane for their help with the ICPMS analyses and for insightful discussions, J. J. Mekalanos for the V. cholerae C6706 Transposon-mutant library, and Inigo Ruiz and David Arranz for their technical support.
Funding Information:
This work was supported by the Knut and Alice Wallenberg Foundation (KAW), The Laboratory of Molecular Infection Medicine Sweden (MIMS), the Swedish Research Council, and the Kempe Foundation. V.C.T. and D.D.S. were supported by the National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) grants P01-AI83211 (Metabolomics Core) and R01-AI125588.
Publisher Copyright:
© 2022 Bueno et al.
PY - 2022/9
Y1 - 2022/9
N2 - The ubiquitous presence of toxic arsenate (AsV) in the environment has raised mechanisms of resistance in all living organisms. Generally, bacterial detoxification of AsV relies on its reduction to arsenite (AsIII) by ArsC, followed by the export of AsIII by ArsB. However, how pathogenic species resist this metalloid remains largely unknown. Here, we found that Vibrio cholerae, the etiologic agent of the diarrheal disease cholera, outcompetes other enteropathogens when grown on millimolar concentrations of AsV. To do so, V. cholerae uses, instead of ArsCB, the AsV-inducible vc1068-1071 operon (renamed var for vibrio arsenate resistance), which encodes the arsenate repressor ArsR, an alternative glyceraldehyde-3-phosphate dehydrogenase, a putative phosphatase, and the AsV transporter ArsJ. In addition to Var, V. cholerae induces oxidative stress-related systems to counter reactive oxygen species (ROS) production caused by intracellular AsV. Characterization of the var mutants suggested that these proteins function independently from one another and play critical roles in preventing deleterious effects on the cell membrane potential and growth derived from the accumulation AsV. Mechanistically, we demonstrate that V. cholerae complexes AsV with the glycolytic intermediate 3-phosphoglycerate into 1-arseno-3-phosphoglycerate (1As3PG). We further show that 1As3PG is not transported outside the cell; instead, it is subsequently dissociated to enable extrusion of free AsV through ArsJ. Collectively, we propose the formation of 1As3PG as a transient metabolic storage of AsV to curb the noxious effect of free AsV. This study advances our understanding of AsV resistance in bacteria and underscores new points of vulnerability that might be an attractive target for antimicrobial interventions.
AB - The ubiquitous presence of toxic arsenate (AsV) in the environment has raised mechanisms of resistance in all living organisms. Generally, bacterial detoxification of AsV relies on its reduction to arsenite (AsIII) by ArsC, followed by the export of AsIII by ArsB. However, how pathogenic species resist this metalloid remains largely unknown. Here, we found that Vibrio cholerae, the etiologic agent of the diarrheal disease cholera, outcompetes other enteropathogens when grown on millimolar concentrations of AsV. To do so, V. cholerae uses, instead of ArsCB, the AsV-inducible vc1068-1071 operon (renamed var for vibrio arsenate resistance), which encodes the arsenate repressor ArsR, an alternative glyceraldehyde-3-phosphate dehydrogenase, a putative phosphatase, and the AsV transporter ArsJ. In addition to Var, V. cholerae induces oxidative stress-related systems to counter reactive oxygen species (ROS) production caused by intracellular AsV. Characterization of the var mutants suggested that these proteins function independently from one another and play critical roles in preventing deleterious effects on the cell membrane potential and growth derived from the accumulation AsV. Mechanistically, we demonstrate that V. cholerae complexes AsV with the glycolytic intermediate 3-phosphoglycerate into 1-arseno-3-phosphoglycerate (1As3PG). We further show that 1As3PG is not transported outside the cell; instead, it is subsequently dissociated to enable extrusion of free AsV through ArsJ. Collectively, we propose the formation of 1As3PG as a transient metabolic storage of AsV to curb the noxious effect of free AsV. This study advances our understanding of AsV resistance in bacteria and underscores new points of vulnerability that might be an attractive target for antimicrobial interventions.
KW - Transposon-seq
KW - Vibrio cholerae
KW - arsenate
KW - arsenite
KW - enteric pathogens
UR - http://www.scopus.com/inward/record.url?scp=85140856289&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85140856289&partnerID=8YFLogxK
U2 - 10.1128/mbio.01654-22
DO - 10.1128/mbio.01654-22
M3 - Article
C2 - 36102515
AN - SCOPUS:85140856289
SN - 2161-2129
VL - 13
JO - mBio
JF - mBio
IS - 5
ER -